QNT Surges 300% on Quant-TCH Bank Partnership
Quant Network’s QNT token rose about 300% in seven days, briefly trading above $270, after The Clearing House (TCH) selected Quant for its On-Chain Money Initiative. QNT trading volume also exceeded $600 million in 24 hours.
TCH is owned by 25 major US banks, including JPMorgan, Bank of America and Citigroup. It operates the RTP real-time payments network and CHIPS wholesale settlement system, which process more than $2 trillion in interbank transactions daily. TCH plans to test a regulated, shared network for programmable, 24-hour transfers between commercial banks in the first half of 2027.
Quant will use its Overledger platform to connect tokenised bank deposits with existing payment rails. The technology supports interoperability, transaction orchestration and near-real-time settlement across different ledgers. The development follows a separate UK trial in which seven major banks, including Barclays, HSBC and Lloyds, completed customer payments using tokenised pound deposits through Quant’s platform.
The partnership strengthens Quant’s position in institutional blockchain infrastructure and may accelerate adoption of tokenised deposits. Unlike USDC and USDT, tokenised deposits remain bank liabilities and may retain deposit protection, while helping banks reduce the risk of deposit disintermediation.
However, TCH has not disclosed the contract value, revenue terms or any requirement to hold QNT. Quant’s software fees can also be paid in US dollars, so institutional adoption may not create sustained spot-market demand for QNT. The rally therefore reflects strong expectations rather than confirmed earnings. Traders should monitor profit-taking and volatility, as well as competition from JPMorgan’s Kinexys and the Canton Network, which includes major institutions such as DTCC, Goldman Sachs, BNY Mellon, HSBC and Visa. Quant must still demonstrate live deployment, revenue growth and effective token value capture.
Bullish
The TCH partnership is bullish for QNT in the short term because it provides major institutional validation and has already triggered a sharp price and volume increase. The UK bank trial adds evidence that Quant’s Overledger platform is moving beyond concept testing toward real-world payment use.
However, the 300% rally also increases the risk of profit-taking, sharp pullbacks and high volatility. TCH has not confirmed contract revenue, QNT usage or a requirement for banks to purchase the token. Because Quant can receive software fees in US dollars, institutional adoption may have only a limited direct effect on QNT demand.
Over the longer term, QNT’s price outlook will depend on whether the US and UK initiatives reach production, generate recurring revenue and create meaningful token value capture. Competition from Kinexys and Canton could limit market share. Overall, the news is bullish for QNT’s narrative and institutional credibility, but the price reaction may remain speculative until commercial results emerge.